Metabolix (MBLX) Reports Better-Than-Expected Q3 Loss of $0.41
More News related to MBLX
- Metabolix (MBLX) Prices 3.45M Shares at $9/Share
- Metabolix Announces Completion of Common Stock Offering
- Morning Movers 11/11: NCST, SMI, MSN, CHLN, NLST, REGN Higher; TGIC, STS, CLWR, STV, MHR, MBLX Lower
- Metabolix (MBLX) Announces 3M Common Share Offering at $9/Share
- Metabolix Prices Common Stock Offering
Metabolix, Inc. (Nasdaq: MBLX) reports Q3 loss of $0.41, 4 cents better than the analyst estimate of ($0.45). Revenue for the quarter was $600, which compares to the estimate of $330K.
Related Categories
EarningsStocks Mentioned
-0.11Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
